CT scans responsible for thousands of cancers each year
Would you believe it if someone told you that no two CT scanners give off the same amount of radiation, and that there is no regulation regarding that amount?
Sad but true. And for some, potentially deadly.
The National Cancer Institute is reporting that CT scans may deliver far more harmful radiation than previously believed, and therefore may be responsible for thousands of cancer diagnoses every year—as many as 29,000 according to their estimate.
About 70 million CT scans are performed annually, and the number is going up. However, radiation amounts differ from one machine to the next, and they can differ by as much as a factor of 13, according to CNN's Dr. Sanjay Gupta.
Check out CNN's coverage of this story HERE.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
